Arun Patel, Founder & Partner at Arunasset Investment Services, recently authored an article for Express Pharma, a publication of The Indian Express Group, on India’s pharmaceutical industry and its transition towards higher-value growth.

In the article, Arun examines pharmaceutical exports, domestic market growth, recent earnings trends, and the challenges facing Indian drugmakers, while highlighting opportunities in complex generics, biosimilars, peptides, and contract manufacturing.
Read the full article: From Volume to Value: How India’s Pharma Industry Can Move Up the Global Value Chain

